HPV immunisation in UK lowers the incidence of cervical cancer and CIN3

Human papillomavirus (HPV) can cause cervical cancer, anogenital cancers and head and neck cancers if long-lasting infections are triggered by high-risk HPV strains, accounting for the great burden of HPV-related cancers worldwide with an estimated incidence in 570,000 women and 600,000 men each year.


Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society

Human papillomavirus (HPV) is one of the most common causes of sexually transmitted disease worldwide. HPV is associated with a variety of clinical conditions that can range from cutaneous warts to cervical or anal cancer. Cervical cancer is the third most common cancer in women in the United States, and may constitute up to 25% of all female cancers in developing countries.